Healthcare stocks: intrinsic value, ROIC & growth
865 U.S. healthcare companies with at least three years of SEC filings, ranked by size. 222 of the 339 with a current price trade below their Graham intrinsic value. The median company earned a -7.9% average return on invested capital and grew revenue 12.8% a year.
Updated October 18, 2026
865companies
222below Graham value
-7.9%median 10-yr ROIC
12.8%median revenue CAGR
Most undervalued healthcare stocks
| Ticker | Company | Upside | Price | Graham value | Price vs value | Market cap | ROIC (10y) | Revenue CAGR |
|---|---|---|---|---|---|---|---|---|
| SRTA | Strata Critical Medical, Inc. | +266% | $4.54 | $16.61 | 73% below | $372.7M | 168.1% | 36.0% |
| CYH | COMMUNITY HEALTH SYSTEMS INC | +182% | $2.88 | $8.13 | 65% below | $388.8M | 4.1% | -4.2% |
| UHS | Universal Health Services | +164% | $185.10 | $488.27 | 62% below | $11.9B | 10.0% | 6.6% |
| AMPH | Amphastar Pharmaceuticals, Inc. | +161% | $25.87 | $67.43 | 62% below | $1.2B | 8.3% | 12.2% |
| ZTS | Zoetis | +152% | $79.38 | $199.96 | 60% below | $35.2B | 22.9% | 7.6% |
| HRMY | Harmony Biosciences Holdings, Inc. | +137% | $37.95 | $90.01 | 58% below | $2.2B | 45.8% | 129.2% |
| CI | Cigna | +123% | $302.30 | $672.81 | 55% below | $81.2B | 10.6% | 23.9% |
| HLF | HERBALIFE LTD. | +122% | $14.60 | $32.34 | 55% below | $1.5B | 47.7% | 1.3% |
| MDXG | MIMEDX GROUP, INC. | +110% | $4.43 | $9.30 | 52% below | $663.3M | 75.7% | 7.3% |
| THC | TENET HEALTHCARE CORP | +92% | $267.25 | $514.51 | 48% below | $24.3B | 13.3% | 0.1% |
Highest-ROIC healthcare stocks
| Ticker | Company | 10-yr ROIC | Price | Graham value | Price vs value | Market cap | ROIC (10y) | Revenue CAGR |
|---|---|---|---|---|---|---|---|---|
| GOSS | Gossamer Bio, Inc. | 193.7% | $8.77 | $69.22 | 87% below | $2.0B | 193.7% | -57.7% |
| NGNE | Neurogene Inc. | 181.7% | $23.25 | $278.16 | 92% below | $495.8M | 181.7% | -42.3% |
| BBIO | BridgeBio Pharma, Inc. | 178.0% | $66.39 | — | — | $12.7B | 178.0% | 52.1% |
| SRTA | Strata Critical Medical, Inc. | 168.1% | $4.54 | $16.61 | 73% below | $372.7M | 168.1% | 36.0% |
| SSII | SS Innovations International, Inc. | 165.8% | $2.53 | — | — | $502.7M | 165.8% | 168.9% |
| TGTX | TG THERAPEUTICS, INC. | 161.3% | $53.97 | $92.01 | 41% below | $8.7B | 161.3% | 151.7% |
| AMRN | AMARIN CORP PLCUK | 140.7% | $11.32 | $0.34 | 3229% above | $4.7B | 140.7% | 5.7% |
| IMCR | Immunocore Holdings plc | 132.3% | £29.40 | — | — | £1.5B | 132.3% | 49.8% |
| AUPH | Aurinia Pharmaceuticals Inc. | 113.0% | $16.51 | $68.76 | 76% below | $2.3B | 113.0% | 150.1% |
| WVE | Wave Life Sciences Ltd. | 112.2% | $3.13 | — | — | $527.9M | 112.2% | 50.3% |
All healthcare stocks (largest 250 of 865)
| Ticker | Company | Price | Graham value | Price vs value | Market cap | ROIC (10y) | Revenue CAGR |
|---|---|---|---|---|---|---|---|
| LLY | Lilly (Eli) | $1,257.03 | $762.30 | 65% above | $1.1T | 26.5% | 13.3% |
| BCAX | Bicara Therapeutics Inc. | $16.78 | — | — | $917.5B | -15.6% | — |
| JNJ | Johnson & Johnson | $255.56 | $233.14 | 10% above | $620.9B | 22.0% | 2.7% |
| AKTX | Akari Therapeutics Plc | $8.18 | — | — | $550.7B | -418.8% | — |
| ONC | BeOne Medicines Ltd. | $369.06 | $6.31 | 5749% above | $544.3B | -64.4% | 157.6% |
| ABBV | AbbVie | $285.42 | — | — | $506.0B | 25.9% | 10.1% |
| MRK | Merck & Co. | $145.95 | $241.81 | 40% below | $365.9B | 15.8% | 5.6% |
| UNH | UnitedHealth Group | $401.43 | $254.76 | 58% above | $365.7B | 17.6% | 10.3% |
| AZN | ASTRAZENECA PLC | $165.41 | $161.48 | 2% above | $256.4B | 11.3% | 11.0% |
| AMGN | Amgen | $432.49 | $195.69 | 121% above | $234.4B | 17.1% | 5.3% |
| GILD | Gilead Sciences | $156.19 | $1.05 | 14775% above | $196.0B | 15.8% | -0.3% |
| ABT | Abbott Laboratories | $104.89 | $123.56 | 15% below | $183.3B | 10.8% | 8.7% |
| PFE | Pfizer | $29.58 | $13.94 | 112% above | $169.0B | 12.3% | 1.9% |
| VRTX | Vertex Pharmaceuticals | $499.74 | $508.86 | 2% below | $128.9B | 34.3% | 24.2% |
| MCK | McKesson Corporation | $1,004.84 | $678.14 | 48% above | $124.7B | -136.3% | 8.2% |
| MDT | Medtronic | $94.75 | $53.01 | 79% above | $122.2B | 6.2% | 1.7% |
| BMY | Bristol Myers Squibb | $59.75 | $43.34 | 38% above | $121.8B | 9.2% | 10.6% |
| CVS | CVS Health | $92.36 | — | — | $117.4B | 7.0% | 9.5% |
| SYK | Stryker Corporation | $294.66 | $171.61 | 72% above | $113.9B | 11.4% | 9.2% |
| HCA | HCA Healthcare | $458.84 | $598.82 | 23% below | $109.9B | -111.2% | 6.9% |
| GSK | GSK PLC | £49.51 | £92.21 | 46% below | £100.3B | 19.8% | 1.8% |
| ELV | Elevance Health | $428.26 | $532.87 | 20% below | $96.2B | 10.2% | 9.9% |
| MMM | 3M | $164.75 | $9.21 | 1689% above | $89.2B | 19.3% | -2.1% |
| REGN | Regeneron Pharmaceuticals | $790.74 | $1,377.79 | 43% below | $85.9B | 23.2% | 12.8% |
| MRNA | Moderna | $218.01 | $668.30 | 67% below | $84.8B | 13.2% | 37.8% |
| CI | Cigna | $302.30 | $672.81 | 55% below | $81.2B | 10.6% | 23.9% |
| COR | Cencora | $340.92 | $94.08 | 262% above | $66.6B | 14.3% | 9.1% |
| BSX | Boston Scientific | $44.39 | $64.44 | 31% below | $66.3B | 6.3% | 10.2% |
| CAH | Cardinal Health | $254.06 | $97.94 | 159% above | $61.5B | -21.9% | 7.0% |
| BDX | Becton Dickinson | $191.75 | $72.00 | 166% above | $55.3B | 5.5% | 6.4% |
| NTRA | Natera, Inc. | $393.44 | — | — | $53.8B | -100.2% | 30.3% |
| HUM | Humana | $413.16 | $247.21 | 67% above | $49.9B | 15.4% | 22.1% |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $41.50 | $40.19 | 3% above | $48.3B | -2.7% | -2.6% |
| IQV | IQVIA | $266.90 | $260.41 | 2% above | $46.3B | 6.1% | 10.2% |
| AGL | agilon health, inc. | $85.12 | — | — | $35.2B | 10.5% | 39.8% |
| ZTS | Zoetis | $79.38 | $199.96 | 60% below | $35.2B | 22.9% | 7.6% |
| RMD | ResMed | $238.97 | $346.44 | 31% below | $34.9B | 19.6% | 11.8% |
| DXCM | Dexcom | $86.04 | $69.42 | 24% above | $34.9B | 73.6% | 26.2% |
| TEVJF | TEVA PHARMACEUTICAL INDUSTRIES LTD | — | $40.19 | — | — | -2.7% | -2.6% |
| RPRX | Royalty Pharma plc | $60.96 | $31.97 | 91% above | $34.4B | 10.2% | 4.1% |
| BIIB | Biogen | $232.65 | — | — | $34.2B | 20.4% | -1.6% |
| CNC | Centene Corporation | $69.16 | $209.59 | 67% below | $34.1B | 4.3% | 18.6% |
| RVMD | Revolution Medicines, Inc. | $177.96 | $64.17 | 177% above | $33.8B | -47.4% | -10.5% |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | $231.83 | $77.39 | 200% above | $31.2B | 373.6% | 62.4% |
| MDLN | Medline Inc. | $35.96 | — | — | $29.1B | 9.4% | 10.6% |
| WST | West Pharmaceutical Services | $384.02 | $225.53 | 70% above | $27.9B | 21.2% | 8.2% |
| LH | Labcorp | $317.95 | $158.47 | 101% above | $26.6B | 9.1% | 4.2% |
| DGX | Quest Diagnostics | $235.00 | $179.52 | 31% above | $26.6B | 11.9% | 4.4% |
| UTHR | UNITED THERAPEUTICS Corp | $533.12 | $536.97 | 1% below | $25.5B | 18.5% | 8.0% |
| ZLAB | Zai Lab Ltd | $23.19 | — | — | $25.4B | -180.0% | 221.3% |
| LGVN | Longeveron Inc. | $1.39 | — | — | $24.4B | -360.5% | 85.2% |
| THC | TENET HEALTHCARE CORP | $267.25 | $514.51 | 48% below | $24.3B | 13.3% | 0.1% |
| ROIV | Roivant Sciences Ltd. | $33.53 | — | — | $23.3B | 94.0% | -19.1% |
| INCY | Incyte | $113.07 | $212.91 | 47% below | $22.7B | 11.7% | 18.6% |
| VTRS | Viatris Inc | $18.66 | $0.66 | 2727% above | $22.3B | 0.6% | 3.4% |
| GH | Guardant Health, Inc. | $158.60 | — | — | $19.9B | 24.6% | 50.2% |
| INSM | INSMED Inc | $96.27 | — | — | $19.2B | -310.9% | 80.2% |
| MEDP | Medpace Holdings, Inc. | $618.47 | $507.54 | 22% above | $18.3B | 53.8% | 22.0% |
| EXEL | EXELIXIS, INC. | $62.23 | $92.34 | 33% below | $17.5B | 22.1% | 46.6% |
| HALO | HALOZYME THERAPEUTICS, INC. | $121.84 | $85.03 | 43% above | $15.1B | 8.9% | 28.4% |
| SOLV | Solventum | $85.81 | $134.22 | 36% below | $15.0B | 12.7% | 0.8% |
| CRL | Charles River Laboratories | $300.15 | $4.23 | 6996% above | $14.9B | 7.9% | 10.2% |
| DVA | DaVita | $187.31 | $207.99 | 10% below | $14.2B | 12.2% | 3.8% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $135.71 | $155.12 | 13% below | $13.9B | 1.5% | 79.2% |
| BTSG | BrightSpring Health Services, Inc. | $60.87 | $28.90 | 111% above | $13.4B | 9.0% | 18.7% |
| CORT | CORCEPT THERAPEUTICS INC | $110.16 | $27.24 | 304% above | $13.2B | 51.0% | 28.2% |
| EHC | Encompass Health Corp | $127.87 | $117.10 | 9% above | $13.1B | 10.0% | 5.6% |
| BAX | Baxter International | $25.28 | $48.74 | 48% below | $13.0B | 6.6% | 1.1% |
| JAZZ | Jazz Pharmaceuticals plc | $210.23 | $248.81 | 16% below | $12.8B | 7.5% | 12.4% |
| BBIO | BridgeBio Pharma, Inc. | $66.39 | — | — | $12.7B | 178.0% | 52.1% |
| PEN | Penumbra Inc | $320.86 | $150.13 | 114% above | $12.6B | 2.5% | 20.4% |
| UHS | Universal Health Services | $185.10 | $488.27 | 62% below | $11.9B | 10.0% | 6.6% |
| ELAN | Elanco Animal Health Inc | $23.55 | $11.43 | 106% above | $11.7B | -2.1% | 5.5% |
| TECH | Bio-Techne | $72.57 | — | — | $11.6B | 10.1% | 10.4% |
| MOH | MOLINA HEALTHCARE, INC. | $207.36 | $296.28 | 30% below | $11.0B | 78.8% | 11.0% |
| SMMT | Summit Therapeutics Inc. | £14.63 | — | — | £10.9B | -206.2% | -21.1% |
| SEM | SELECT MEDICAL HOLDINGS CORP | — | $15.01 | — | — | 8.3% | 2.9% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.68 | — | — | $10.8B | -0.8% | 12.5% |
| HSIC | Henry Schein | $86.38 | $27.42 | 215% above | $10.5B | 13.0% | 1.5% |
| GMED | GLOBUS MEDICAL INC | $76.71 | $130.21 | 41% below | $10.5B | 9.3% | 20.1% |
| PODD | Insulet Corporation | $141.10 | $115.59 | 22% above | $10.1B | 7.7% | 24.9% |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | $449.74 | — | — | $10.1B | -148.1% | 432.1% |
| KRYS | Krystal Biotech, Inc. | $316.58 | $227.20 | 39% above | $9.5B | -78.0% | 177.0% |
| GKOS | GLAUKOS Corp | $164.84 | $12.29 | 1241% above | $9.4B | -16.6% | 18.0% |
| KYMR | Kymera Therapeutics, Inc. | $104.78 | — | — | $8.9B | -30.3% | 54.0% |
| TGTX | TG THERAPEUTICS, INC. | $53.97 | $92.01 | 41% below | $8.7B | 161.3% | 151.7% |
| PCVX | Vaxcyte, Inc. | $63.62 | — | — | $8.7B | -33.9% | — |
| IBRX | ImmunityBio, Inc. | $9.18 | — | — | $8.4B | 29.0% | 139.3% |
| OSCR | Oscar Health, Inc. | $31.89 | — | — | $8.4B | 18.0% | -37.7% |
| PTGX | Protagonist Therapeutics, Inc | $128.75 | $89.41 | 44% above | $8.2B | -56.6% | 10.9% |
| TWST | Twist Bioscience Corp | $132.75 | — | — | $7.9B | -15.5% | 55.9% |
| AXSM | Axsome Therapeutics, Inc. | $157.14 | — | — | $7.8B | 1247.3% | 71.3% |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $55.90 | $22.92 | 144% above | $7.5B | -117.6% | 159.0% |
| CHE | CHEMED CORP | $512.38 | $387.66 | 32% above | $7.4B | 26.9% | 5.4% |
| SCNI | Scinai Immunotherapeutics Ltd. | $0.75 | — | — | $7.0B | 143.4% | -77.4% |
| ALKS | Alkermes plc. | $41.22 | $29.93 | 38% above | $7.0B | 0.9% | 7.9% |
| IONS | IONIS PHARMACEUTICALS INC | $42.94 | $43.97 | 2% below | $6.9B | -17.0% | 10.9% |
| VREOF | Vireo Growth Inc. | $9.00 | — | — | $6.6B | -4.0% | 40.4% |
| AMRX | Amneal Pharmaceuticals, Inc. | $19.18 | — | — | $6.2B | 4.3% | 12.8% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $78.59 | — | — | $6.2B | -32.4% | 104.8% |
| LGND | LIGAND PHARMACEUTICALS INC | $295.54 | $203.61 | 45% above | $6.0B | 16.4% | 10.5% |
| TFX | TELEFLEX INC | $130.43 | $12.69 | 928% above | $5.8B | 7.2% | 0.7% |
| HAE | HAEMONETICS CORP | $118.28 | $43.33 | 173% above | $5.6B | 6.8% | 4.7% |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | $86.17 | — | — | $5.6B | -109.4% | 178.5% |
| PRAX | Praxis Precision Medicines, Inc. | $241.76 | — | — | $5.4B | -633.7% | 249.5% |
| MMSI | MERIT MEDICAL SYSTEMS INC | $89.20 | $70.75 | 26% above | $5.4B | 4.5% | 10.8% |
| PTCT | PTC THERAPEUTICS, INC. | $59.24 | $258.42 | 77% below | $5.2B | -53.1% | 40.2% |
| RDNT | RadNet, Inc. | $68.80 | $0.85 | 7994% above | $5.2B | 3.9% | 9.7% |
| SHC | Sotera Health Co | $17.89 | — | — | $5.1B | 7.2% | 6.9% |
| CAI | Caris Life Sciences, Inc. | $30.56 | — | — | $5.1B | 8.0% | 62.9% |
| OPCH | Option Care Health, Inc. | $31.20 | $38.52 | 19% below | $5.1B | 5.5% | 22.1% |
| IMVT | Immunovant, Inc. | $26.73 | — | — | $4.9B | 1000.6% | — |
| AMRN | AMARIN CORP PLCUK | $11.32 | $0.34 | 3229% above | $4.7B | 140.7% | 5.7% |
| CGON | CG Oncology, Inc. | $59.85 | — | — | $4.6B | -18.6% | 345.0% |
| LFST | LifeStance Health Group, Inc. | $11.74 | $0.82 | 1332% above | $4.6B | -7.9% | 37.3% |
| SRRK | Scholar Rock Holding Corp | $39.90 | — | — | $4.6B | -92.9% | 17.4% |
| KOD | Kodiak Sciences Inc. | $85.75 | — | — | $4.6B | 6913.9% | — |
| ITGR | Integer Holdings Corp | $126.70 | $95.99 | 32% above | $4.5B | 5.8% | 6.2% |
| CRSP | CRISPR Therapeutics AG | $49.25 | $0.41 | 11912% above | $4.4B | -19.9% | -4.2% |
| TVTX | Travere Therapeutics, Inc. | $49.60 | — | — | $4.4B | -233.1% | 15.6% |
| GRAL | GRAIL, Inc. | $117.81 | — | — | $4.3B | -52.9% | 25.7% |
| LIVN | LivaNova PLC | $77.58 | $16.75 | 363% above | $4.2B | -2.0% | 4.1% |
| INDV | Indivior Pharmaceuticals, Inc. | $32.45 | $23.06 | 41% above | $4.2B | -34.4% | 11.9% |
| ICUI | ICU MEDICAL INC/DE | $162.99 | — | — | $4.1B | 5.0% | 21.8% |
| MIRM | Mirum Pharmaceuticals, Inc. | $80.14 | — | — | $4.0B | -43.9% | 128.4% |
| EWTX | Edgewise Therapeutics, Inc. | $37.19 | — | — | $3.8B | -20.2% | — |
| COGT | Cogent Biosciences, Inc. | $29.52 | — | — | $3.8B | 636.7% | -2.0% |
| ERAS | Erasca, Inc. | $13.39 | — | — | $3.8B | 22.8% | — |
| GPCR | Structure Therapeutics Inc. | $21.08 | — | — | $3.7B | -7.2% | — |
| ARQT | Arcutis Biotherapeutics, Inc. | $28.82 | — | — | $3.7B | -62.1% | 365.6% |
| ADPT | Adaptive Biotechnologies Corp | $24.02 | — | — | $3.6B | -17.9% | 28.0% |
| OGN | Organon & Co. | $13.76 | — | — | $3.6B | 21.0% | -3.7% |
| ABCL | AbCellera Biologics Inc. | $11.80 | $16.61 | 29% below | $3.5B | 2.7% | 36.5% |
| IRTC | iRhythm Holdings, Inc. | $108.66 | — | — | $3.5B | -90.1% | 31.4% |
| VCYT | VERACYTE, INC. | $43.12 | $27.24 | 58% above | $3.5B | -38.0% | 25.9% |
| CDNA | CareDx, Inc. | $64.00 | $30.89 | 107% above | $3.4B | -49.5% | 28.2% |
| ACAD | ACADIA PHARMACEUTICALS INC | $19.12 | $76.40 | 75% below | $3.2B | -35.1% | 58.1% |
| MASI | MASIMO CORP | — | $31.92 | — | — | 32.6% | 11.2% |
| DNLI | Denali Therapeutics Inc. | $17.61 | $20.93 | 16% below | $3.0B | -22.0% | 20.7% |
| LQDA | Liquidia Corp | $34.35 | — | — | $3.0B | -307.1% | 64.2% |
| IDYA | IDEAYA Biosciences, Inc. | $32.85 | — | — | $2.9B | -1.8% | 62.1% |
| PRVA | Privia Health Group, Inc. | $22.52 | $5.12 | 340% above | $2.9B | -18.2% | 18.0% |
| GRDN | Guardian Pharmacy Services, Inc. | $39.47 | — | — | — | -9.2% | 17.9% |
| TMDX | TransMedics Group, Inc. | $70.78 | $161.76 | 56% below | $2.9B | -32.1% | 70.2% |
| TARS | Tarsus Pharmaceuticals, Inc. | $68.07 | — | — | $2.8B | 33.8% | 67.7% |
| VKTX | Viking Therapeutics, Inc. | $25.17 | — | — | $2.8B | -62.1% | — |
| RLAY | Relay Therapeutics, Inc. | $16.28 | $67.59 | 76% below | $2.8B | -43.9% | -28.6% |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | $72.09 | $78.78 | 8% below | $2.8B | -56.1% | -15.1% |
| ATRC | AtriCure, Inc. | $56.07 | $35.72 | 57% above | $2.7B | -7.7% | 14.7% |
| XENE | Xenon Pharmaceuticals Inc. | $33.49 | — | — | $2.7B | -56.9% | 17.2% |
| AVAH | Aveanna Healthcare Holdings, Inc. | $12.34 | $22.19 | 44% below | $2.7B | 6.3% | 11.9% |
| CELC | Celcuity Inc. | $56.58 | — | — | $2.6B | -1303.5% | — |
| ADMA | ADMA BIOLOGICS, INC. | $10.68 | $19.93 | 46% below | $2.6B | 6239.1% | 53.7% |
| TNGX | Tango Therapeutics, Inc. | $22.04 | — | — | $2.6B | -211.1% | 52.1% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $26.34 | $23.25 | 13% above | $2.5B | -67.0% | 574.3% |
| PBH | Prestige Consumer Healthcare Inc. | $49.92 | $82.65 | 40% below | $2.4B | 6.5% | 2.4% |
| PGNY | Progyny, Inc. | $26.86 | $12.28 | 119% above | $2.4B | 12.2% | 50.6% |
| RCUS | Arcus Biosciences, Inc. | $22.12 | $23.58 | 6% below | $2.4B | -46.2% | 48.3% |
| BHC | Bausch Health Companies Inc. | $6.30 | — | — | $2.4B | 0.8% | 0.7% |
| NAMS | NewAmsterdam Pharma Co N.V. | $19.83 | $105.24 | 81% below | $2.3B | 324.0% | -39.7% |
| MD | Pediatrix Medical Group, Inc. | $27.38 | — | — | $2.3B | 3.1% | -5.5% |
| BEAM | Beam Therapeutics Inc. | $23.47 | — | — | $2.3B | 93.1% | 345.0% |
| PRGO | PERRIGO Co plc | $16.63 | $3.45 | 382% above | $2.3B | -1.7% | -2.4% |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | $4.48 | — | — | $2.3B | -101.3% | 26.8% |
| AUPH | Aurinia Pharmaceuticals Inc. | $16.51 | $68.76 | 76% below | $2.3B | 113.0% | 150.1% |
| UFPT | UFP TECHNOLOGIES INC | $291.67 | $290.64 | 0% above | $2.3B | 12.1% | 17.1% |
| HRMY | Harmony Biosciences Holdings, Inc. | $37.95 | $90.01 | 58% below | $2.2B | 45.8% | 129.2% |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | $37.88 | $42.36 | 11% below | $2.1B | 15.6% | 14.3% |
| ADUS | Addus HomeCare Corp | $115.98 | $173.39 | 33% below | $2.1B | 8.2% | 15.1% |
| NRIX | Nurix Therapeutics, Inc. | $24.42 | — | — | $2.1B | -46.2% | 18.0% |
| VCEL | Vericel Corp | $40.13 | $10.63 | 278% above | $2.1B | -17.0% | 19.8% |
| BLLN | BillionToOne, Inc. | $98.12 | $4.65 | 2010% above | $2.1B | 13.4% | 106.2% |
| INSP | Inspire Medical Systems, Inc. | $68.79 | $162.42 | 58% below | $2.0B | -18.9% | 56.2% |
| FTRE | Fortrea Holdings Inc. | $22.49 | $5.24 | 329% above | $2.0B | -8.2% | -2.9% |
| IRON | Disc Medicine, Inc. | $56.84 | — | — | $2.0B | -17.1% | — |
| GOSS | Gossamer Bio, Inc. | $8.77 | $69.22 | 87% below | $2.0B | 193.7% | -57.7% |
| PGEN | PRECIGEN, INC. | $6.39 | — | — | $2.0B | -84.4% | -28.2% |
| NVAX | NOVAVAX INC | $11.26 | $85.70 | 87% below | $1.9B | 639.3% | 61.1% |
| RTEZ | REST EZ Inc. | $70.00 | — | — | $1.9B | -141.2% | -63.8% |
| ZYME | Zymeworks Inc. | $25.03 | $63.11 | 60% below | $1.9B | -58.3% | 22.2% |
| SGRY | Surgery Partners, Inc. | $14.61 | $5.78 | 153% above | $1.9B | 7.4% | 12.5% |
| LMAT | LEMAITRE VASCULAR INC | $80.82 | $83.70 | 3% below | $1.9B | 13.4% | 12.1% |
| DYN | Dyne Therapeutics, Inc. | $14.25 | — | — | $1.8B | -248.0% | — |
| WGS | GeneDx Holdings Corp. | $63.61 | — | — | $1.8B | -785.5% | 13.9% |
| MBX | MBX Biosciences, Inc. | $49.61 | — | — | $1.8B | -44.8% | — |
| VERA | Vera Therapeutics, Inc. | $27.88 | — | — | $1.8B | -80.3% | — |
| XERS | Xeris Biopharma Holdings, Inc. | $10.31 | — | — | $1.8B | -53.5% | 70.7% |
| HTFL | Heartflow, Inc. | $48.29 | — | — | $1.8B | 12.5% | 42.1% |
| INVA | Innoviva, Inc. | $20.78 | $109.61 | 81% below | $1.8B | 40.2% | 13.3% |
| SRPT | Sarepta Therapeutics, Inc. | $17.10 | $77.72 | 78% below | $1.7B | -35.7% | 91.3% |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $7.79 | $40.19 | 81% below | $1.7B | -67.0% | 47.6% |
| XNCR | Xencor Inc | $22.85 | $13.78 | 66% above | $1.7B | -11.4% | 1.6% |
| ARDT | Ardent Health, Inc. | $11.95 | — | — | $1.7B | 11.1% | 7.2% |
| SDGR | Schrodinger, Inc. | $22.60 | $17.94 | 26% above | $1.7B | -27.9% | 20.0% |
| ALHC | Alignment Healthcare, Inc. | $8.28 | — | — | $1.6B | 549.3% | 31.8% |
| PCRX | Pacira BioSciences, Inc. | $36.34 | — | — | $1.6B | 3.2% | 11.6% |
| SEPN | Septerna, Inc. | $36.35 | $9.63 | 277% above | $1.6B | -68.5% | 1644.5% |
| TRVI | Trevi Therapeutics, Inc. | $11.88 | — | — | $1.6B | 37.7% | — |
| AXGN | Axogen, Inc. | $34.62 | — | — | $1.6B | -40.8% | 20.8% |
| CUE | Cue Biopharma, Inc. | $16.71 | — | — | $1.6B | 230.8% | 57.5% |
| PAHC | PHIBRO ANIMAL HEALTH CORP | $38.82 | $25.15 | 54% above | $1.6B | 15.2% | 6.2% |
| ATEC | Alphatec Holdings, Inc. | $10.46 | — | — | $1.6B | -55.4% | 22.8% |
| NVCR | NovoCure Ltd | $14.07 | $5.98 | 135% above | $1.6B | -161.2% | 25.8% |
| RXRX | RECURSION PHARMACEUTICALS, INC. | $3.46 | — | — | $1.6B | -269.1% | 78.4% |
| ANIP | ANI PHARMACEUTICALS INC | $72.29 | $110.28 | 34% below | $1.5B | 4.2% | 23.9% |
| HLF | HERBALIFE LTD. | $14.60 | $32.34 | 55% below | $1.5B | 47.7% | 1.3% |
| IMCR | Immunocore Holdings plc | £29.40 | — | — | £1.5B | 132.3% | 49.8% |
| PNTG | Pennant Group, Inc. | $41.87 | $22.35 | 87% above | $1.5B | 6.1% | 18.1% |
| CNMD | CONMED Corp | $46.72 | $43.82 | 7% above | $1.5B | 5.0% | 6.8% |
| IMNM | Immunome Inc. | $16.47 | $106.42 | 85% below | $1.4B | -707.0% | -29.6% |
| SKIN | SkinHealth Systems Inc. | $10.56 | — | — | $1.4B | 4.4% | 10.3% |
| RARE | Ultragenyx Pharmaceutical Inc. | $14.54 | — | — | $1.4B | -149.9% | 158.0% |
| STOK | Stoke Therapeutics, Inc. | $24.17 | — | — | $1.4B | 430.8% | 145.9% |
| PSNL | Personalis, Inc. | $15.65 | — | — | $1.4B | -30.4% | 28.5% |
| INBX | Inhibrx Biosciences, Inc. | $89.83 | — | — | $1.4B | 1218.9% | -15.0% |
| VIR | Vir Biotechnology, Inc. | $9.96 | $127.22 | 92% below | $1.4B | 8.4% | 49.8% |
| MLYS | Mineralys Therapeutics, Inc. | $20.30 | — | — | $1.4B | -22.4% | — |
| PVLA | PALVELLA THERAPEUTICS, INC. | $120.30 | $14.42 | 734% above | $1.4B | 97.2% | 31.1% |
| ANAB | ANAPTYSBIO, INC | $46.61 | — | — | $1.3B | -170.3% | 34.1% |
| USPH | U S PHYSICAL THERAPY INC /NV | $85.71 | $6.47 | 1225% above | $1.3B | 12.5% | 9.1% |
| OCUL | OCULAR THERAPEUTIX, INC | $6.87 | — | — | $1.3B | 66.8% | 44.5% |
| DBVT | DBV Technologies S.A. | $9.05 | $1.67 | 442% above | $1.3B | -4355.3% | -5.2% |
| QURE | uniQure N.V. | $21.78 | — | — | $1.3B | 861.9% | -4.8% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $25.87 | $67.43 | 62% below | $1.2B | 8.3% | 12.2% |
| SLN | Silence Therapeutics plc | £8.68 | — | — | £1.2B | 75.0% | 14.8% |
| TRUP | TRUPANION, INC. | $28.12 | $14.95 | 88% above | $1.2B | -8.3% | 25.4% |
| INNV | InnovAge Holding Corp. | $8.85 | $4.02 | 120% above | $1.2B | -4.1% | 8.5% |
| MAZE | Maze Therapeutics, Inc. | $27.53 | — | — | $1.2B | 41.6% | — |
| CPRX | CATALYST PHARMACEUTICALS, INC. | — | $55.80 | — | — | -171.8% | 174.6% |
| BHVN | Biohaven Ltd. | $10.78 | — | — | $1.2B | -276.7% | — |
| TSHA | Taysha Gene Therapies, Inc. | $3.62 | — | — | $1.2B | 924.1% | 57.5% |
| OPK | OPKO HEALTH, INC. | $1.53 | — | — | $1.1B | -8.1% | -6.6% |
| IRMD | IRADIMED CORP | $88.27 | $50.97 | 73% above | $1.1B | 44.8% | 11.1% |
| ABSI | Absci Corp | $8.25 | $4.59 | 80% above | $1.1B | 52.6% | -7.4% |
| SNDX | Syndax Pharmaceuticals Inc | $12.90 | $15.28 | 16% below | $1.1B | -155.0% | 73.3% |
| ZBIO | Zenas BioPharma, Inc. | $24.84 | $743.16 | 97% below | $1.1B | -83.5% | -55.3% |
| TYRA | Tyra Biosciences, Inc. | $18.52 | — | — | $1.1B | -202.5% | — |
| TNDM | TANDEM DIABETES CARE INC | $16.24 | $7.97 | 104% above | $1.1B | -67.1% | 31.9% |
| SLS | SELLAS Life Sciences Group, Inc. | $9.98 | $10.01 | 0% below | $1.1B | 630.0% | -27.4% |
| IMUX | IMMUNIC, INC. | $6.97 | — | — | $1.1B | 380.4% | — |
| ORIC | Oric Pharmaceuticals, Inc. | $12.35 | — | — | $1.1B | -47.0% | — |
| RAPP | Rapport Therapeutics, Inc. | $27.57 | — | — | $1.1B | -35.0% | — |
| ORKA | Oruka Therapeutics, Inc. | $71.93 | — | — | $1.0B | 440.7% | — |
| AORT | ARTIVION, INC. | $21.78 | — | — | $1.0B | 2.7% | 10.4% |
| NOTV | Inotiv, Inc. | — | $6.31 | — | — | -12.1% | 43.1% |
| JANX | Janux Therapeutics, Inc. | $16.51 | — | — | $1.0B | -12.5% | 28.8% |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $13.21 | $14.44 | 9% below | $1.0B | 3.1% | 5.7% |
| REPL | Replimune Group, Inc. | $10.86 | — | — | $1.0B | -55.9% | — |
| CMPS | COMPASS Pathways plc | $10.75 | — | — | $1.0B | -260.8% | — |
| HROW | HARROW, INC. | $27.28 | $0.33 | 8167% above | $1.0B | -18.8% | 33.7% |
Industries in healthcare
Biological Products 143
Commercial Physical & Biological Research 15
Electromedical & Electrotherapeutic Apparatus 33
General Medical & Surgical Hospitals 6
Health Services 18
Home Health Care Services 7
Hospital & Medical Service Plans 10
Medical Laboratories 24
Misc Health & Allied Services 10
Pharmaceutical Preparations 454
Retail-Drug Stores and Proprietary Stores 5
Surgical & Medical Instruments & Apparatus 118
Wholesale-Drugs, Proprietaries & Druggists' Sundries 9
Stock lists
Undervalued Stocks Below Graham Intrinsic Value
Highest ROIC Stocks (10-Year Average)
Highest Free Cash Flow Yield Stocks
Fastest-Growing Stocks by 10-Year Revenue